Get access

Interventions for psychosexual dysfunction in women treated for gynaecological malignancy

  • Review
  • Intervention




Psychosexual dysfunction (sexual difficulties not directly due to physical factors) is known to be a common complication of treatment for gynaecological cancer. It has a considerable impact on quality of life (QoL) for the increasing number of women who are survivors of gynaecological cancer.


To determine the effectiveness of interventions for psychosexual dysfunction in women who have been treated for gynaecological malignancy (cancer of uterine cervix, uterine corpus, ovary, vulva).

Search methods

We searched the Cochrane Central Register of Controlled Trials (CENTRAL, up to October 2008), MEDLINE (1950 to October 2008), EMBASE (1982 to October 2008), CINAHL (1980 to October 2008) and PsycINFO (1806 to October 2008). We hand searched reference lists from eligible trials.

Selection criteria

We selected all randomized controlled trials (RCTs) of a medical or psychological intervention to prevent or treat psychosexual dysfunction in adult women previously treated for gynaecological cancer.

Data collection and analysis

We selected five studies for inclusion in this review and analysed any outcome data relating to resumption of sexual intercourse, DSM-IV diagnoses or validated scales of sexual functioning. Sensitivity analysis was performed where possible.

Main results

The review included data from 5 studies, comprising a total of 413 patients, examining 5 different interventions. One trial suggested a short-term benefit for the use of vaginal Dienoestrol in women after pelvic radiotherapy (NNT = 4). Another trial suggested a short-term benefit for one regime of low dose-rate brachytherapy over another but this modality is not in widespread use. Studies of a Clinical Nurse Specialist intervention, Psychoeducational Group Therapy and a Couple-Coping intervention, did not show any significant benefit. All the studies were of poor methodological quality.

Authors' conclusions

There is no convincing evidence to support the use of any interventions for psychosexual dysfunction in women treated for gynaecological cancer. There is a need for more studies of high methodological quality.








Cochrane Central Register of Controlled Trials(CENTRAL、2008年10月まで)、MEDLINE(1950年~2008年10月)、EMBASE(1982年~2008年10月)、CINAHL(1980年~2008年10月)およびPsycINFO(1806年~2008年10月)を検索した。適格な試験からの参考文献リストをハンドサーチした。










監  訳: 吉田 雅博,2009.9.15

実施組織: 厚生労働省委託事業によりMindsが実施した。

ご注意 : この日本語訳は、臨床医、疫学研究者などによる翻訳のチェックを受けて公開していますが、訳語の間違いなどお気づきの点がございましたら、Minds事務局までご連絡ください。Mindsでは最新版の日本語訳を掲載するよう努めておりますが、編集作業に伴うタイム・ラグが生じている場合もあります。ご利用に際しては、最新版(英語版)の内容をご確認ください。

Plain language summary

Interventions for psychosexual dysfunction in women treated for gynaecological malignancy

This systematic review found very few good quality trials of interventions to treat or prevent psychosexual problems occurring in women after treatment for gynaecological cancer. They were mostly small studies and all examined different types of interventions. This review found only weak evidence to support the use of vaginal oestrogen, some low dose-rate brachytherapy regimes and a number of psychological interventions.

Get access to the full text of this article